Literature DB >> 9678700

Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.

A K Ryan1, K Bartlett, P Clayton, S Eaton, L Mills, D Donnai, R M Winter, J Burn.   

Abstract

We have reviewed all known UK cases of Smith-Lemli-Opitz syndrome. Among 49 cases with proven 7-dehydrocholesterol reductase deficiency, half had been terminated or had died in infancy. The minimum incidence is 1 in 60,000. The frequent occurrence of hypospadias may account for 71% of recognised cases being male. Important common features which emerged include short thumbs, severe photosensitivity, aggressive behaviour, and atrioventricular septal defect. The typical facial appearance becomes less obvious with age and 20% of cases did not have 2/3 toe syndactyly. Biochemical measurements of serum 7-dehydrocholesterol did not correlate with clinical severity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678700      PMCID: PMC1051366          DOI: 10.1136/jmg.35.7.558

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

Authors:  D W SMITH; L LEMLI; J M OPITZ
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

2.  Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

Authors:  E R Elias; M B Irons; A D Hurley; G S Tint; G Salen
Journal:  Am J Med Genet       Date:  1997-01-31

3.  Phenotypic diversity in the Smith-Lemli-Opitz syndrome.

Authors:  M J Seller; F A Flinter; Z Docherty; N Fagg; M Newbould
Journal:  Clin Dysmorphol       Date:  1997-01       Impact factor: 0.816

4.  Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?

Authors:  R L Kelley; E Roessler; R C Hennekam; G L Feldman; K Kosaki; M C Jones; J C Palumbos; M Muenke
Journal:  Am J Med Genet       Date:  1996-12-30

5.  Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism.

Authors:  C Cunniff; L E Kratz; A Moser; M R Natowicz; R I Kelley
Journal:  Am J Med Genet       Date:  1997-01-31

6.  Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome.

Authors:  N A Nwokoro; J J Mulvihill
Journal:  Am J Med Genet       Date:  1997-01-31

7.  Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry.

Authors:  P A Zimmerman; D M Hercules; E W Naylor
Journal:  Am J Med Genet       Date:  1997-01-31

8.  Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome.

Authors:  D B Dehart; L Lanoue; G S Tint; K K Sulik
Journal:  Am J Med Genet       Date:  1997-01-31

Review 9.  Cardiovascular malformations in Smith-Lemli-Opitz syndrome.

Authors:  A E Lin; H H Ardinger; R H Ardinger; C Cunniff; R I Kelley
Journal:  Am J Med Genet       Date:  1997-01-31

10.  Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: probable disruption of an SLOS gene.

Authors:  M Wallace; R T Zori; T Alley; E Whidden; B A Gray; C A Williams
Journal:  Am J Med Genet       Date:  1994-05-01
View more
  48 in total

Review 1.  Detection of inborn errors of metabolism in the newborn.

Authors:  A Chakrapani; M A Cleary; J E Wraith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

3.  Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens.

Authors:  L Starck; A Lövgren
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

4.  A novel mutation of the DHCR7 gene in a sicilian compound heterozygote with Smith-Lemli-Opitz Syndrome.

Authors:  Fabrizio Romano; Barbara Fiore; Franca Maria Pezzino; Maria Teresa Longombardo; Angelo Baldassare Cefalù; Davide Noto; Ambra Puglisi; Alfio Brogna; Teresa Mattina; Maurizio Averna; Salvatore Travali
Journal:  Mol Diagn       Date:  2005

Review 5.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

6.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

7.  Molecular screening of Smith-Lemli-Opitz syndrome in pregnant women from the Czech Republic.

Authors:  I Blahakova; E Makaturova; L Kotrbova; M Soukupova; J Lastuvkova; L Kozak
Journal:  J Inherit Metab Dis       Date:  2007-11-12       Impact factor: 4.982

8.  Clinical utility gene card for: Smith-Lemli-Opitz Syndrome [SLOS].

Authors:  Martina Witsch-Baumgartner; Hilary Sawyer; Dorothea Haas
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

9.  Intracranial undifferentiated malign neuroglial tumor in Smith-Lemli-Opitz syndrome: A theory of a possible predisposing factor for primary brain tumors via a case report.

Authors:  Ayfer Aslan; Alp Ozgun Borcek; Selma Pamukcuoglu; M Kemali Baykaner
Journal:  Childs Nerv Syst       Date:  2016-08-15       Impact factor: 1.475

10.  Challenging behavior in Smith-Lemli-Opitz syndrome: initial test of biobehavioral influences.

Authors:  Kurt A Freeman; Rose Eagle; Louise S Merkens; Darryn Sikora; Kersti Pettit-Kekel; Mina Nguyen-Driver; Robert D Steiner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.